{"id":"https://openalex.org/W4236337378","doi":"https://doi.org/10.1161/circ.118.suppl_18.s_497-b","title":"Abstract 3885: Adenosine A 2A and A 2B Receptors Work in Concert to Produce a Strong Protection against Reperfusion Injury by Targeting the mPTP via a GSK-3\u03b2-Dependent Mechanism","display_name":"Abstract 3885: Adenosine A 2A and A 2B Receptors Work in Concert to Produce a Strong Protection against Reperfusion Injury by Targeting the mPTP via a GSK-3\u03b2-Dependent Mechanism","publication_year":2008,"publication_date":"2008-10-28","ids":{"openalex":"https://openalex.org/W4236337378","doi":"https://doi.org/10.1161/circ.118.suppl_18.s_497-b"},"language":"en","primary_location":{"id":"doi:10.1161/circ.118.suppl_18.s_497-b","doi":"https://doi.org/10.1161/circ.118.suppl_18.s_497-b","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.118.suppl_18.s_497-b","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5019759097","display_name":"Jinkun Xi","orcid":"https://orcid.org/0000-0002-5220-1192","observed_orcids":["https://orcid.org/0000-0002-5220-1192"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jinkun Xi","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":null,"display_name":"SungRyul Lee","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"SungRyul Lee","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Min Zhu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Min Zhu","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022159261","display_name":"Rachel McIntosh","orcid":"https://orcid.org/0009-0000-9736-8431","observed_orcids":["https://orcid.org/0009-0000-9736-8431"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rachel McIntosh","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111807691","display_name":"Robert A. Mueller","orcid":"https://orcid.org/0000-0002-4835-6335","observed_orcids":["https://orcid.org/0000-0002-4835-6335"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert A Mueller","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035629125","display_name":"Edward A. Norfleet","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edward A Norfleet","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5009871804","display_name":"Zhelong Xu","orcid":"https://orcid.org/0000-0003-0430-2906","observed_orcids":["https://orcid.org/0000-0003-0430-2906"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhelong Xu","raw_affiliation_strings":["UNC Chapel Hill, Chapel Hill, NC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UNC Chapel Hill, Chapel Hill, NC","institution_ids":["https://openalex.org/I114027177"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"118","issue":"suppl_18","first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11057","display_name":"Cardiac Ischemia and Reperfusion","score":0.7246000170707703,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11057","display_name":"Cardiac Ischemia and Reperfusion","score":0.7246000170707703,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11193","display_name":"Adenosine and Purinergic Signaling","score":0.2660999894142151,"subfield":{"id":"https://openalex.org/subfields/1314","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10301","display_name":"Mitochondrial Function and Pathology","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adenosine-a2a-receptor","display_name":"adenosine A2A receptor","score":0.9860000014305115},{"id":"https://openalex.org/keywords/adenosine-a2b-receptor","display_name":"adenosine A2B receptor","score":1.0},{"id":"https://openalex.org/keywords/ischemia-reperfusion-injury","display_name":"ischemia-reperfusion injury","score":0.9290000200271606},{"id":"https://openalex.org/keywords/cardioprotection","display_name":"cardioprotection","score":0.8270000219345093},{"id":"https://openalex.org/keywords/mitochondrial-permeability-transition-pore","display_name":"mitochondrial permeability transition pore","score":0.9879999756813049},{"id":"https://openalex.org/keywords/gsk-3beta","display_name":"GSK3\u03b2","score":0.9290000200271606},{"id":"https://openalex.org/keywords/glycogen-synthase-kinase-3beta","display_name":"glycogen synthase kinase-3\u03b2","score":0.7870000004768372},{"id":"https://openalex.org/keywords/mitochondrial-membrane-potential","display_name":"mitochondrial membrane potential","score":0.7710000276565552},{"id":"https://openalex.org/keywords/neca","display_name":"NECA","score":0.628000020980835},{"id":"https://openalex.org/keywords/infarct-size","display_name":"infarct size","score":0.7300000190734863},{"id":"https://openalex.org/keywords/cardiomyocytes","display_name":"cardiomyocytes","score":0.8009999990463257},{"id":"https://openalex.org/keywords/oxidative-stress","display_name":"oxidative stress","score":0.640999972820282},{"id":"https://openalex.org/keywords/cgs-21680","display_name":"CGS 21680","score":0.7649999856948853},{"id":"https://openalex.org/keywords/sch58261","display_name":"SCH58261","score":0.9100000262260437}],"concepts":[{"id":"https://openalex.org/C13591479","wikidata":"https://www.wikidata.org/wiki/Q6881880","display_name":"Mitochondrial permeability transition pore","level":4,"score":0.7248001098632812},{"id":"https://openalex.org/C2779676291","wikidata":"https://www.wikidata.org/wiki/Q25325349","display_name":"Cardioprotection","level":3,"score":0.6807911396026611},{"id":"https://openalex.org/C2778674702","wikidata":"https://www.wikidata.org/wiki/Q239816","display_name":"MPTP","level":4,"score":0.6606138348579407},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.600408673286438},{"id":"https://openalex.org/C2776991684","wikidata":"https://www.wikidata.org/wiki/Q190012","display_name":"Adenosine","level":2,"score":0.5812898874282837},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.570790708065033},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5117813944816589},{"id":"https://openalex.org/C2780114680","wikidata":"https://www.wikidata.org/wiki/Q1413991","display_name":"Reperfusion injury","level":3,"score":0.4878830909729004},{"id":"https://openalex.org/C28859421","wikidata":"https://www.wikidata.org/wiki/Q39572","display_name":"Mitochondrion","level":2,"score":0.4623957574367523},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.43451565504074097},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.4187595844268799},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.40255770087242126},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.34835195541381836},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.2993827760219574},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.2934248447418213},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2691625654697418},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.19951993227005005},{"id":"https://openalex.org/C541997718","wikidata":"https://www.wikidata.org/wiki/Q188151","display_name":"Ischemia","level":2,"score":0.14625325798988342},{"id":"https://openalex.org/C31573885","wikidata":"https://www.wikidata.org/wiki/Q304484","display_name":"Programmed cell death","level":3,"score":0.10351809859275818},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.07776007056236267},{"id":"https://openalex.org/C2779734285","wikidata":"https://www.wikidata.org/wiki/Q11085","display_name":"Parkinson's disease","level":3,"score":0.0655091404914856},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1161/circ.118.suppl_18.s_497-b","doi":"https://doi.org/10.1161/circ.118.suppl_18.s_497-b","is_oa":false,"landing_page_url":"https://doi.org/10.1161/circ.118.suppl_18.s_497-b","pdf_url":null,"source":{"id":"https://openalex.org/S116251202","display_name":"Circulation","issn_l":"0009-7322","issn":["0009-7322","1524-4539"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Circulation","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1985927695","https://openalex.org/W1969139369","https://openalex.org/W2031582285","https://openalex.org/W2059275861","https://openalex.org/W2333153638","https://openalex.org/W2773709046","https://openalex.org/W2885095485","https://openalex.org/W2591506557","https://openalex.org/W7099550103","https://openalex.org/W1998453171"],"abstract_inverted_index":{"While":[0],"the":[1,98,108,120,126,160,254,280],"role":[2,24],"of":[3,11,36,86,129,171,181,188,237,256],"adenosine":[4],"A":[5,37,40,99,109,173,176,225,228,289,292],"2":[6],"receptor":[7,121],"activation":[8,170],"in":[9,73,89,125,193,204,296],"modulation":[10],"reperfusion":[12,49,69,163,300],"injury":[13,50,301],"has":[14],"been":[15],"extensively":[16],"investigated,":[17],"controversies":[18],"still":[19],"exist":[20],"regarding":[21],"its":[22],"exact":[23],"(protective":[25],"or":[26,271],"not).":[27],"We":[28],"aimed":[29],"to":[30,141,298],"test":[31],"if":[32],"a":[33,45,235,250,306],"simultaneous":[34],"stimulation":[35],"2A":[38,100,174,226,240,290],"and":[39,58,107,138,153,167,175,214,227,242,291],"2B":[41,110,177,229,247,293],"receptors":[42,294],"can":[43],"produce":[44],"strong":[46],"protection":[47,252],"against":[48,253],"by":[51,96,150,164,211,222,265,302],"targeting":[52,165,303],"mitochondrial":[53,189],"permeability":[54],"transition":[55],"pore":[56],"(mPTP)":[57],"glycogen":[59],"synthase":[60],"kinase":[61],"3\u03b2":[62],"(GSK-3\u03b2).":[63],"NECA":[64,131,157,184,218],"(100":[65],"nM)":[66],"given":[67],"at":[68,135,162],"reduced":[70],"infarct":[71],"size":[72],"isolated":[74],"rat":[75],"hearts":[76],"(14.1":[77],"\u00b1":[78,83,104,114,196,201,259,268,276],"1.9":[79],"%":[80,85,198,203],"vs.":[81,199],"37.9":[82],"3.1":[84],"risk":[87],"zone":[88],"control),":[90,205],"an":[91,145],"effect":[92,128,146],"that":[93,118,147,156,217,234,263,288],"was":[94,148,207],"blocked":[95,149,210],"both":[97,119,151,172,212,224],"antagonist":[101,111],"SCH58261":[102,152,213],"(36.6":[103],"2.4":[105],"%)":[106,261,270],"MRS1706":[112],"(39.2":[113],"2.9":[115,269],"%),":[116],"indicating":[117,216],"subtypes":[122],"are":[123],"involved":[124],"anti-infarct":[127],"NECA.":[130],"increased":[132],"GSK-3\u03b2":[133,140,166],"phosphorylation":[134],"Ser":[136],"9":[137],"translocated":[139],"mitochondria":[142,168],"upon":[143],"reperfusion,":[144],"MRS1706,":[154,215],"implying":[155],"may":[158],"protect":[159],"heart":[161],"through":[169,305],"receptors.":[178,230],"In":[179,283],"support":[180],"this":[182],"interpretation,":[183],"prevented":[185],"oxidant-induced":[186],"loss":[187,255],"membrane":[190],"potential":[191],"(MMP)":[192],"cardiomyocytes":[194],"(91.2":[195],"3.7":[197],"38.8":[200],"5.4":[202],"which":[206],"also":[208],"partially":[209],"prevents":[219],"mPTP":[220,304],"opening":[221],"stimulating":[223],"Further":[231],"experiments":[232],"showed":[233],"combination":[236],"CGS21680":[238,266],"(A":[239,246],"agonist)":[241,248],"BAY60":[243,272],"\u2013":[244,273],"6583":[245,274],"induced":[249,264],"greater":[251],"MMP":[257],"(84.7":[258],"1.1":[260],"than":[262],"(55.6":[267],"(63.7":[275],"5.0)":[277],"alone,":[278],"corroborating":[279],"above":[281],"observations.":[282],"conclusion,":[284],"these":[285],"data":[286],"suggest":[287],"work":[295],"concert":[297],"prevent":[299],"GSK-3\u03b2-dependent":[307],"mechanism.":[308]},"counts_by_year":[],"updated_date":"2026-09-27T08:07:27.782135","created_date":"2022-05-12T00:00:00"}